By proceeding, you agree to our Terms of Use and Privacy Policy.
Senior Principal Scientist
#ophthalmology #disease
#Northamerica
Aditya Venkatesh is currently working as Senior Principal Scientist at Stoke Therapeutics.
Clinical Assistant Professor
#disease #medical
#NorthAmerica
I am currently a visiting professor at the Community Eye Clinic in Fort Worth, TX and the Cedar Springs Eye Clinic in Dallas, TX There we provide medical eye care to many underserved populations with
US Advocacy Lead - Rare Disease
#disease #sales
Aprill Lane is US Advocacy Lead - Rare Disease at UCB
Principal Scientist
#research #disease
I am a capable, hard-working and inquisitive individual with a deep drive to understand the underlying basis of disease using a combination of biophysical and cellular approaches. I am particularly in
Head of Rare Disease
#Disease #clinical
#Europe
A highly experienced leader working in rare and ultra-rare diseases.
Senior Fellow & Editor-at-Large for Public Health
#disease #epidemiologistjournalism #medicine
Dr. Celine Gounder is a practicing HIV/infectious diseases specialist and internist, epidemiologist (aka disease detective), journalist and filmmaker.
Owner, Optometrist
#eyemanagement #glaucoma #disease
Dr. David Dinh hails from Baton Rouge, Louisiana where he received his undergraduate degree from Louisiana State University in Biological Sciences with a minor in Chemistry.
Lecturer in Immunology
#disease #vaccination #microgliaactivity
I am originally from Havana-Cuba, where I graduated as Biochemist to then pursue a doctorate in Molecular Medicine and Immunology in Milan-Italy; I then joined the University of Oxford. Currently I ho
Director
#disease #hgp #chemical
Francis Collins is an extremely accomplished scientist. He discovered how to identify specific genes and what function they served. This opened up research opportunities to cure diseases and disorders
Vice President, Pharmaceutical Development
#vaccine #genetherapy #disease
Gene Therapy, Vaccine, and Rare Disease Product Development Executive, committed to improving global human health by systematically driving the advancement of new and improved medicines with sound sci
Chairman Of The Board
#strategy #medicine #disease
Dr. Levin is the Chairman and CEO of Ovid Therapeutics, Inc., a public company developing novel medicines to treat rare diseases of the brain. Prior to Ovid, Dr. Levin served as President and CEO of T
VP, Head of US Public Affairs & Patient Advocacy - Rare Diseases
Kate Tighe is Vice President and Head of US Public Affairs and Patient Advocacy for Rare Diseases at Sanofi.